Industry: Medical Devices & Consumables
Published Date: 2024-10-01
Pages: 137 Pages
Report ld: 3335730
Request Sample
Customized Report
Human plasma is an important component of blood. It is a liquid without cell components obtained by centrifugation after the whole blood leaves the blood vessels and is anticoagulated. Human serum refers to the light yellow transparent liquid separated from the plasma by removing fibrinogen after blood coagulation, or plasma without fibrinogen. It is an invisible component of blood and is different from plasma in composition.
The global Human Serum and Plasma market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
The US & Canada market for Human Serum and Plasma is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The China market for Human Serum and Plasma is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The Europe market for Human Serum and Plasma is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key manufacturers of Human Serum and Plasma include Akron, Baxter, Cytiva, Merck Millipore, Monobind, SeraCare, TCS Biosciences Ltd, Thermo Fisher, Trina Bioreactives, Zen-Bio, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Human Serum and Plasma, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Human Serum and Plasma, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Human Serum and Plasma, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Human Serum and Plasma sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Human Serum and Plasma market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Human Serum and Plasma sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Akron, Baxter, Cytiva, Merck Millipore, Monobind, SeraCare, TCS Biosciences Ltd, Thermo Fisher, Trina Bioreactives, Zen-Bio, etc.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Human Serum and Plasma in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Human Serum and Plasma manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Serum and Plasma sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Human Serum and Plasma Product Introduction
1.2 Market by Type
1.2.1 Global Human Serum and Plasma Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Fresh Human Serum and Plasma
1.2.3 Frozen Human Serum and Plasma
1.3 Market by Application
1.3.1 Global Human Serum and Plasma Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 In Vitro Diagnostics
1.3.3 Vaccines and Antibodies
1.3.4 Cell Culture
1.3.5 Clinical Research
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Human Serum and Plasma Revenue Estimates and Forecasts 2019-2030
2.2 Global Human Serum and Plasma Revenue by Region
2.2.1 Global Human Serum and Plasma Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Human Serum and Plasma Revenue by Region (2019-2024)
2.2.3 Global Human Serum and Plasma Revenue by Region (2025-2030)
2.2.4 Global Human Serum and Plasma Revenue Market Share by Region (2019-2030)
2.3 Global Human Serum and Plasma Sales Estimates and Forecasts 2019-2030
2.4 Global Human Serum and Plasma Sales by Region
2.4.1 Global Human Serum and Plasma Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Human Serum and Plasma Sales by Region (2019-2024)
2.4.3 Global Human Serum and Plasma Sales by Region (2025-2030)
2.4.4 Global Human Serum and Plasma Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Human Serum and Plasma Sales by Manufacturers
3.1.1 Global Human Serum and Plasma Sales by Manufacturers (2019-2024)
3.1.2 Global Human Serum and Plasma Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Human Serum and Plasma in 2023
3.2 Global Human Serum and Plasma Revenue by Manufacturers
3.2.1 Global Human Serum and Plasma Revenue by Manufacturers (2019-2024)
3.2.2 Global Human Serum and Plasma Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Human Serum and Plasma Revenue in 2023
3.3 Global Key Players of Human Serum and Plasma, Industry Ranking, 2021 VS 2022
3.4 Global Human Serum and Plasma Sales Price by Manufacturers (2019-2024)
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Human Serum and Plasma Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Human Serum and Plasma, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Human Serum and Plasma, Product Offered and Application
3.8 Global Key Manufacturers of Human Serum and Plasma, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Human Serum and Plasma Sales by Type
4.1.1 Global Human Serum and Plasma Historical Sales by Type (2019-2024)
4.1.2 Global Human Serum and Plasma Forecasted Sales by Type (2025-2030)
4.1.3 Global Human Serum and Plasma Sales Market Share by Type (2019-2030)
4.2 Global Human Serum and Plasma Revenue by Type
4.2.1 Global Human Serum and Plasma Historical Revenue by Type (2019-2024)
4.2.2 Global Human Serum and Plasma Forecasted Revenue by Type (2025-2030)
4.2.3 Global Human Serum and Plasma Revenue Market Share by Type (2019-2030)
4.3 Global Human Serum and Plasma Price by Type
4.3.1 Global Human Serum and Plasma Price by Type (2019-2024)
4.3.2 Global Human Serum and Plasma Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Human Serum and Plasma Sales by Application
5.1.1 Global Human Serum and Plasma Historical Sales by Application (2019-2024)
5.1.2 Global Human Serum and Plasma Forecasted Sales by Application (2025-2030)
5.1.3 Global Human Serum and Plasma Sales Market Share by Application (2019-2030)
5.2 Global Human Serum and Plasma Revenue by Application
5.2.1 Global Human Serum and Plasma Historical Revenue by Application (2019-2024)
5.2.2 Global Human Serum and Plasma Forecasted Revenue by Application (2025-2030)
5.2.3 Global Human Serum and Plasma Revenue Market Share by Application (2019-2030)
5.3 Global Human Serum and Plasma Price by Application
5.3.1 Global Human Serum and Plasma Price by Application (2019-2024)
5.3.2 Global Human Serum and Plasma Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Human Serum and Plasma Market Size by Type
6.1.1 US & Canada Human Serum and Plasma Sales by Type (2019-2030)
6.1.2 US & Canada Human Serum and Plasma Revenue by Type (2019-2030)
6.2 US & Canada Human Serum and Plasma Market Size by Application
6.2.1 US & Canada Human Serum and Plasma Sales by Application (2019-2030)
6.2.2 US & Canada Human Serum and Plasma Revenue by Application (2019-2030)
6.3 US & Canada Human Serum and Plasma Market Size by Country
6.3.1 US & Canada Human Serum and Plasma Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Human Serum and Plasma Revenue by Country (2019-2030)
6.3.3 US & Canada Human Serum and Plasma Sales by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Human Serum and Plasma Market Size by Type
7.1.1 Europe Human Serum and Plasma Sales by Type (2019-2030)
7.1.2 Europe Human Serum and Plasma Revenue by Type (2019-2030)
7.2 Europe Human Serum and Plasma Market Size by Application
7.2.1 Europe Human Serum and Plasma Sales by Application (2019-2030)
7.2.2 Europe Human Serum and Plasma Revenue by Application (2019-2030)
7.3 Europe Human Serum and Plasma Market Size by Country
7.3.1 Europe Human Serum and Plasma Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Human Serum and Plasma Revenue by Country (2019-2030)
7.3.3 Europe Human Serum and Plasma Sales by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Human Serum and Plasma Market Size by Type
8.1.1 China Human Serum and Plasma Sales by Type (2019-2030)
8.1.2 China Human Serum and Plasma Revenue by Type (2019-2030)
8.2 China Human Serum and Plasma Market Size by Application
8.2.1 China Human Serum and Plasma Sales by Application (2019-2030)
8.2.2 China Human Serum and Plasma Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Human Serum and Plasma Market Size by Type
9.1.1 Asia Human Serum and Plasma Sales by Type (2019-2030)
9.1.2 Asia Human Serum and Plasma Revenue by Type (2019-2030)
9.2 Asia Human Serum and Plasma Market Size by Application
9.2.1 Asia Human Serum and Plasma Sales by Application (2019-2030)
9.2.2 Asia Human Serum and Plasma Revenue by Application (2019-2030)
9.3 Asia Human Serum and Plasma Market Size by Region
9.3.1 Asia Human Serum and Plasma Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Human Serum and Plasma Revenue by Region (2019-2030)
9.3.3 Asia Human Serum and Plasma Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
9.3.9 Australia
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Human Serum and Plasma Market Size by Type
10.1.1 Middle East, Africa and Latin America Human Serum and Plasma Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Human Serum and Plasma Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Human Serum and Plasma Market Size by Application
10.2.1 Middle East, Africa and Latin America Human Serum and Plasma Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Human Serum and Plasma Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Human Serum and Plasma Market Size by Country
10.3.1 Middle East, Africa and Latin America Human Serum and Plasma Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Human Serum and Plasma Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Human Serum and Plasma Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Corporate Profile
11.1 Akron
11.1.1 Akron Company Information
11.1.2 Akron Overview
11.1.3 Akron Human Serum and Plasma Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Akron Human Serum and Plasma Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Akron Recent Developments
11.2 Baxter
11.2.1 Baxter Company Information
11.2.2 Baxter Overview
11.2.3 Baxter Human Serum and Plasma Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Baxter Human Serum and Plasma Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Baxter Recent Developments
11.3 Cytiva
11.3.1 Cytiva Company Information
11.3.2 Cytiva Overview
11.3.3 Cytiva Human Serum and Plasma Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Cytiva Human Serum and Plasma Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Cytiva Recent Developments
11.4 Merck Millipore
11.4.1 Merck Millipore Company Information
11.4.2 Merck Millipore Overview
11.4.3 Merck Millipore Human Serum and Plasma Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Merck Millipore Human Serum and Plasma Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Merck Millipore Recent Developments
11.5 Monobind
11.5.1 Monobind Company Information
11.5.2 Monobind Overview
11.5.3 Monobind Human Serum and Plasma Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Monobind Human Serum and Plasma Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Monobind Recent Developments
11.6 SeraCare
11.6.1 SeraCare Company Information
11.6.2 SeraCare Overview
11.6.3 SeraCare Human Serum and Plasma Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 SeraCare Human Serum and Plasma Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 SeraCare Recent Developments
11.7 TCS Biosciences Ltd
11.7.1 TCS Biosciences Ltd Company Information
11.7.2 TCS Biosciences Ltd Overview
11.7.3 TCS Biosciences Ltd Human Serum and Plasma Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 TCS Biosciences Ltd Human Serum and Plasma Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 TCS Biosciences Ltd Recent Developments
11.8 Thermo Fisher
11.8.1 Thermo Fisher Company Information
11.8.2 Thermo Fisher Overview
11.8.3 Thermo Fisher Human Serum and Plasma Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Thermo Fisher Human Serum and Plasma Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Thermo Fisher Recent Developments
11.9 Trina Bioreactives
11.9.1 Trina Bioreactives Company Information
11.9.2 Trina Bioreactives Overview
11.9.3 Trina Bioreactives Human Serum and Plasma Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Trina Bioreactives Human Serum and Plasma Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Trina Bioreactives Recent Developments
11.10 Zen-Bio
11.10.1 Zen-Bio Company Information
11.10.2 Zen-Bio Overview
11.10.3 Zen-Bio Human Serum and Plasma Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Zen-Bio Human Serum and Plasma Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Zen-Bio Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Human Serum and Plasma Industry Chain Analysis
12.2 Human Serum and Plasma Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Human Serum and Plasma Production Mode & Process
12.4 Human Serum and Plasma Sales and Marketing
12.4.1 Human Serum and Plasma Sales Channels
12.4.2 Human Serum and Plasma Distributors
12.5 Human Serum and Plasma Customers
13 Human Serum and Plasma Market Dynamics
13.1 Human Serum and Plasma Industry Trends
13.2 Human Serum and Plasma Market Drivers
13.3 Human Serum and Plasma Market Challenges
13.4 Human Serum and Plasma Market Restraints
14 Key Findings in the Global Human Serum and Plasma Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Human Serum and Plasma market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 141
USD 4900.00
(Single User License)
The global Human Serum and Plasma market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 76
USD 4250.00
(Single User License)
The global market for Human Serum and Plasma was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-09
Pages: 101
USD 3950.00
(Single User License)
The global Human Serum and Plasma market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-09
Pages: 116
USD 2900.00
(Single User License)
The global Human Serum and Plasma market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 144
USD 4900.00
(Single User License)
The global Human Serum and Plasma market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 76
USD 4250.00
(Single User License)
The global market for Human Serum and Plasma was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 107
USD 3950.00
(Single User License)
The global market for Human Serum and Plasma was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 86
USD 2900.00
(Single User License)
Human plasma is an important component of blood. It is a liquid without cell components obtained by centrifugation after the whole blood leaves the blood vessels and is anticoagulated. Human serum refers to the light yellow transparent liquid separated from the plasma by removing fibrinogen after blood coagulation, or plasma without fibrinogen. It is an invisible component of blood and is different from plasma in composition.
Published Date: 2024-10-01
Pages: 83
USD 2900.00
(Single User License)
Human plasma is an important component of blood. It is a liquid without cell components obtained by centrifugation after the whole blood leaves the blood vessels and is anticoagulated. Human serum refers to the light yellow transparent liquid separated from the plasma by removing fibrinogen after blood coagulation, or plasma without fibrinogen. It is an invisible component of blood and is different from plasma in composition.
Published Date: 2024-10-01
Pages: 116
USD 4350.00
(Single User License)
The global Human Serum and Plasma market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 141
The global Human Serum and Plasma market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 76
The global market for Human Serum and Plasma was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-09
Pages: 101
The global Human Serum and Plasma market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-09
Pages: 116
The global Human Serum and Plasma market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 144
The global Human Serum and Plasma market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 76
The global market for Human Serum and Plasma was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 107
The global market for Human Serum and Plasma was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 86
Human plasma is an important component of blood. It is a liquid without cell components obtained by centrifugation after the whole blood leaves the blood vessels and is anticoagulated. Human serum refers to the light yellow transparent liquid separated from the plasma by removing fibrinogen after blood coagulation, or plasma without fibrinogen. It is an invisible component of blood and is different from plasma in composition.
Published: 2024-10-01
Pages: 83
Human plasma is an important component of blood. It is a liquid without cell components obtained by centrifugation after the whole blood leaves the blood vessels and is anticoagulated. Human serum refers to the light yellow transparent liquid separated from the plasma by removing fibrinogen after blood coagulation, or plasma without fibrinogen. It is an invisible component of blood and is different from plasma in composition.
Published: 2024-10-01
Pages: 116
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now